Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common. In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury in the course of COVID 19 disease.
Description: To evaluate the frequency of presence of fever in patients with and without pancreatic injury
Measure: to compare presence of fever in patients with and without pancreatic injury Time: 3 monthDescription: To evaluate the frequency of presence of dyspnea in patients with and without pancreatic injury
Measure: to compare presence of dyspnea in patients with and without pancreatic injury Time: 3 monthDescription: CRP levels will be compared in patients with and without pancreatic injury
Measure: To compare cRP levels in patients with and without pancreatic injury Time: 3 monthDescription: D-Dimer levels will be compared in patients with and without pancreatic injury
Measure: To compare d-dimer levels in patients with and without pancreatic injury Time: 3 month